This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Continuous Glucose Monitoring tools are revolutionizing the way diabetes is mana...
Medical device companies that leverage today’s technology to better share and tr...
Next-generation robotic platforms have made a significant leap forward with real...
This potential for self-management can reduce the burden on the healthcare syste...
Access to minimally invasive treatment of complex vascular conditions is still l...
Hospitals would be much better served by focusing on reuse and reprocessing prog...
In part 2 of our Q&A, Okamura addresses the need for biopharma companies to leve...
Scott Davis is the CEO of Ekso Bionics, an innovative medical device company mak...
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the ...
The next wave of Medtech innovation must deliver truly smart connected care—not ...
The FDA awarded marketing authorization for a new Invitae test that uses next-ge...
Allurion Technologies has commercialized a gastric balloon in the form of a pill...
Pear Therapeutics was once regarded as a digital therapeutics pioneer, but its s...
More effective and proactive care requires a framework that will enable the U.S....
The MedTech industry has demonstrated remarkable resilience in navigating uncert...
The good news is that virtual solutions are becoming more sophisticated every da...
We must think beyond one-size-fits-all solutions and embrace the diversity of ob...
Patients who were previously facing challenges like needing oxygen after just a ...
Wearables don’t just tell us what a patient is doing — they can help us understa...
Effective diabetes management requires a shift from focusing purely on blood sug...
Wearable devices, such as a glucose meter device or a defibrillator and pacemake...
To improve outcomes further, healthcare providers will need to take bold action ...
Right to repair would undermine the FDA’s regulations and introduce unnecessary ...
The current model of siloed, proprietary development is failing us. It’s slow, e...